洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2400091460】A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial

基本信息
登记号

ChiCTR2400091460

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2024-10-29

临床申请受理号

/

靶点

/

适应症

/

试验通俗题目

A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial

试验专业题目

A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

The study is to evaluate the effectiveness of the group-based compassionate mind training (CMT) protocol on patients' psychopathology conditions, fears of compassion and self-compassion. The study would also consider participants' homework compliance in the evaluation of treatment outcomes.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

Participants will be allocated to the intervention group or control group (1:1 ratio) randomly. A research assistant who is not involved in the intervention would generate the random numbers by computer.

盲法

/

试验项目经费来源

Self-finance

试验范围

/

目标入组人数

64

实际入组人数

/

第一例入组时间

2024-10-30

试验终止时间

2025-12-31

是否属于一致性

/

入选标准

Inclusion criteria: 1) aged 18 or above, 2) patients from psychiatric and/or clinical psychology outpatient clinics who are experiencing depressive disorders, particularly major depressive disorder, persistent depressive disorder, and other specified depressive disorder (operationalized as fulfilling the criteria in Diagnostic and Statistical Manual of Mental Disorders: Fifth edition, text revision (DSM-V-TR)). Clinical psychologists would further verify the diagnosis with reference to the DSM-V-TR criteria. 3) Meanwhile, recruited participants’ concurrent psychotrophic medications were said to be stable during the study.;

排除标准

Patients with neurodevelopmental disorders, schizophrenia spectrum and other psychotic disorders, bipolar disorders, obsessive-compulsive disorders, comorbid substance use disorder, personality disorders, potential risks to self and/or others, neurocognitive disorders, intellectual disabilities, physical disabilities, severe medical illnesses (such as newly diagnosis at acute phase, potential to undergo intensive treatment), who could not read Chinese and speak in Cantonese, who did not read and write, as well as those who had previously received compassion-based or mindfulness-based interventions.;

研究者信息
研究负责人姓名
请登录查看
试验机构

Department of Psychology, The Chinese University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用